Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 201688
Company: MYLAN SPECIALITY LP
Company: MYLAN SPECIALITY LP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TOBI PODHALER | TOBRAMYCIN | 28MG | POWDER;INHALATION | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/22/2013 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD; Orphan |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201688s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/201688Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/201688Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/201688Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/10/2023 | SUPPL-19 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201688s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/201688Orig1s019ltr.pdf | |
07/13/2020 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201688s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/201688Orig1s010ltr.pdf | |
01/27/2017 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/16/2016 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201688s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/201688Orig1s008ltr.pdf | |
01/06/2016 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
10/02/2015 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201688s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/201688Orig1s006ltr.pdf | |
09/11/2015 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/19/2014 | SUPPL-4 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201688s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201688Orig1s004ltr.pdf | |
09/30/2014 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/25/2014 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201688s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201688Orig1s002ltr.pdf | |
01/07/2014 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
02/10/2023 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201688s019lbl.pdf | |
07/13/2020 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201688s010lbl.pdf | |
12/16/2016 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201688s008lbl.pdf | |
10/02/2015 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201688s006lbl.pdf | |
11/19/2014 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201688s004lbl.pdf | |
04/25/2014 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201688s002lbl.pdf | |
03/22/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201688s000lbl.pdf |